Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anteis is a Swiss medical technology company specializing in the development and manufacture of injectable biopolymers for aesthetic and therapeutic use. Founded in 2003 and based in Geneva, the company pioneered the Cohesive Polydensified Matrix (CPM) technology, which produces hyaluronic acid gels with unique rheological properties. Its flagship product line, Belotero, is a globally recognized brand of dermal fillers used for wrinkle correction and facial volumization. Beyond aesthetics, Anteis develops specialized gels for orthopedic viscosupplementation and ophthalmic surgery. The company was acquired by Merz Pharma in 2013, serving as a key innovation and production site for the Merz Aesthetics division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anteis.